FDA Accelerates Biosimilar Approvals to Lower Prescription Costs The U.S. Food and Drug Administration (FDA) has introduced a new framework designed to simplify and speed up the approval process for biosimilar drugs — generic versions of complex biological medicines used to treat conditions such as cancer, autoimmune disorders, and rare
In the ongoing global fight against Alzheimer’s disease, new hope is emerging from a surprising source — a pill. Researchers have unveiled promising new results for ALZ-801, an oral medication that appears to slow cognitive decline among individuals at the highest genetic risk of developing the condition. The drug’s novel
Louisiana is under scrutiny after officials delayed warnings about the state’s most severe whooping cough outbreak in decades. The delay resulted in multiple infant deaths and hundreds of hospitalizations. The incident has reignited debates about vaccine hesitancy, public health transparency, and the growing politicization of disease prevention in the United
Rural Hospitals Face Unprecedented Staffing Pressure When the Trump administration imposed a $100,000 fee on new H-1B visa applications, the move was framed as an effort to prioritize American workers. But for rural hospitals across the United States, the policy has triggered alarm. The H-1B visa fee impact on U.S.
The Rise of Science-Driven Wellness Goals In a world flooded with wellness trends, supplements, and influencer advice, the search for genuine, evidence-based health guidance, including setting science-based wellness goals, has become more important than ever. A groundbreaking new study from leading researchers in behavioral science is changing how we understand
Surge in Coverage and Cost for GLP-1 Weight-Loss Drugs in the Workplace In recent years, a new class of medications known as glucagon-like peptide-1 (GLP-1) agonists—originally developed for diabetes—have emerged as highly effective treatments for weight loss. These drugs, such as those listed at more than US$1,300 per month for
The Ancient Mystery of Fever: From Fear to Function At some point, everyone has endured the heat, chills, and disorientation that accompany a fever. Though unpleasant, this rise in temperature is far from meaningless. It’s an ancient survival mechanism developed over hundreds of millions of years. Scientists now understand that
Antidepressants Show Vast Differences in Physical Side Effects For the first time, antidepressants have been ranked according to their physical health effects. This sheds light on major variations among widely used medications. Researchers from King’s College London and the University of Oxford analyzed over 150 studies involving 30 antidepressants and
How Early Peanut Exposure Transformed Childhood Allergy Prevention For decades, parents were urged to keep infants away from peanuts to avoid dangerous allergic reactions. But modern research has completely flipped that advice — and the results have been life-changing. Over the past ten years, a major shift in pediatric nutrition
A Milestone in Japan’s Reproductive Health Policy Japan has officially approved the over-the-counter sale of the emergency contraceptive pill, marking a turning point in the nation’s approach to women’s reproductive rights. The medication, produced by ASKA Pharmaceutical, will now be available without a doctor’s prescription for the first time, offering women
LaGuardia Plane Crash Investigation Highlights Air Traffic Control Staffing Concerns and System Failures After Fatal Runway Collision The investigation into the fatal runway collision at LaGuardia Airport is increasingly focused on systemic challenges within air traffic control operations, particularly staffing procedures and workload distribution during overnight shifts. The crash, which
FISA Section 702 Reauthorization Sparks Debate Over Data Broker Loophole as Lawmakers Weigh Limits on Warrantless Surveillance A growing political and legal debate in Washington is intensifying ahead of the upcoming reauthorization of Section 702 of the Foreign Intelligence Surveillance Act (FISA), a key surveillance authority set to expire in
DHS Funding Deal in Jeopardy as Trump and Senate Democrats Withhold Support Amid Immigration and TSA Crisis A fragile proposal to fund key operations of the Department of Homeland Security (DHS) is facing mounting uncertainty as both Donald Trump and Senate Democrats decline to fully support the emerging framework. The